Procedure: intra-articular injection of etanercept (DrugBank: Etanercept)
15 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
15 | Inclusion body myositis | 0 |
28 | Systemic amyloidosis | 0 |
35 | Pemphigus | 0 |
38 | Stevens-Johnson syndrome | 0 |
39 | Toxic epidermal necrolysis | 0 |
46 | Malignant rheumatoid arthritis | 1 |
50 | Dermatomyositis | 0 |
53 | Sjogren syndrome | 0 |
56 | Behcet disease | 0 |
60 | Aplastic anemia | 0 |
85 | Idiopathic interstitial pneumonia | 0 |
228 | Bronchiolitis obliterans | 0 |
271 | Ankylosing spondylitis | 0 |
285 | Fanconi anemia | 0 |
298 | Hereditary pancreatitis | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00522184 (ClinicalTrials.gov) | February 2005 | 27/8/2007 | Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study | Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study for Evaluation of Efficacy and Safety of Etanercept Versus Intra-Articular Steroid Injection in Acute Synovitis | Rheumatoid Arthritis | Procedure: intra-articular injection of etanercept;Procedure: intra-articular injection of steroid | Centre Hospitalier Universitaire de Nice | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | 18 Years | N/A | Both | 34 | Phase 3 | France |